Regulus Receives Final Milestone Payment From Biogen For Multiple Sclerosis Development
October 28, 2015 at 14:46 PM EDT
Today Regulus Therapeutics (RGLS) announced that it has received its fourth and final milestone payment from Biogen (BIIB).
